I now have comprehensive, authoritative content from Sabiston's and Schwartz's Surgery. Here is the full detailed explanation:
Phases of Normal Wound Healing
Wound healing is a dynamic, continuous process that unfolds over four overlapping phases. The phases do not simply stop and start - they exist as a continuum, and each phase must complete in an orderly, timely fashion for repair to succeed. Disruption of any phase - by diabetes, infection, ischaemia, or malnutrition - can lock a wound in a dysfunctional cycle.
Cell kinetics across the phases of wound healing. Neutrophils dominate early inflammation; macrophages bridge inflammation to proliferation; fibroblasts dominate the proliferative phase.
Phase 1 - Haemostasis (Seconds to Hours)
Goal: Stop bleeding and seal the wound.
Key events:
-
Vascular injury triggers intense arteriolar vasoconstriction (mediated by catecholamines and prostaglandins), followed by vasodilatation and increased capillary permeability
-
Platelet adhesion to the damaged endothelium is mediated by glycoprotein receptors (GPIa/IIa) binding to exposed collagen, and GPIIb-IIIa binding fibronectin, vitronectin, and fibrinogen; von Willebrand factor (vWF) is essential for initial platelet-collagen contact
-
Platelet activation triggers release from two organelles:
- Alpha granules → PDGF, TGF-β, IGF-1, fibronectin, fibrinogen, thrombospondin, vWF
- Dense bodies → serotonin and vasoactive amines → vasodilation and increased permeability
-
Mast cells release histamine and serotonin, further increasing endothelial permeability
-
Platelet membrane-bound factor V + factor X generate prothrombinase, activating thrombin, which converts fibrinogen to fibrin clot (the provisional wound matrix)
-
The fibrin clot also acts as a scaffold for subsequent cell migration
-
Growth factors released (PDGF, TGF-β, VEGF, PF4, CD40L) create a chemotactic gradient that recruits inflammatory cells and initiates the next phase
-
Sabiston Textbook of Surgery | Schwartz's Principles of Surgery, 11th Ed.
Phase 2 - Inflammation (Days 1-4)
Goal: Clear debris, bacteria, and devitalised tissue; prepare the wound bed.
Vascular changes: The increased permeability established during haemostasis allows plasma proteins and leukocytes to flood the wound. Clinically: redness, warmth, swelling, pain, and loss of function (the cardinal signs of inflammation).
Neutrophils (PMNs) - first responders, peak day 1-2
- Arrive within hours of injury, peak at ~48 hours
- Primary functions: phagocytosis of bacteria and debris; release of reactive oxygen species (ROS) for bacterial killing; release of proteases (elastase, collagenase) to break down devitalised tissue
- Not essential for healing in clean wounds (animal models show healing can proceed without neutrophils if infection is controlled), but essential when contamination is present
- Apoptose and are cleared by macrophages as the wound becomes clean
Macrophages - the "master regulators," peak day 3-4
Macrophages are the most important cells in wound healing. They arrive shortly after neutrophils and persist into the proliferative phase. Their functions span 7 categories:
- Phagocytosis of apoptotic neutrophils, bacteria, and foreign material
- Reactive oxygen species - bacterial lysis
- Nitric oxide - kills antibiotic-resistant bacteria
- Cytokine secretion - IL-1, IL-2, IL-4, IL-12
- Angiogenesis - via VEGF, promoting capillary budding
- Cell recruitment - recruits fibroblasts and endothelial cells into the wound
- Homeostatic regulation - wound repair, follicle regeneration
Macrophage depletion before injury causes profound defects: failed re-epithelialisation, absent granulation tissue, no angiogenesis, and no myofibroblast-mediated wound contraction. Depletion at day 9 has no effect, confirming macrophages are dispensable later.
Two macrophage phenotypes exist:
- M1 (classically activated) - pro-inflammatory; dominant early; kills bacteria; secretes TNF-α, IL-6
- M2 (alternatively activated) - anti-inflammatory; dominant later; promotes tissue repair, collagen synthesis, angiogenesis
Lymphocytes - appear late, peak day 7
- Modulate the transition from inflammation to proliferation
- T-helper cells secrete cytokines that regulate fibroblast activity
What determines chronicity: The inflammatory phase is the fork in the road between acute and chronic wounds. In chronic wounds, persistent pro-inflammatory conditions trap the wound in a self-perpetuating cycle where PMNs and macrophages continually degrade newly formed matrix, preventing progression to proliferation.
- Sabiston Textbook of Surgery | Schwartz's Principles of Surgery, 11th Ed.
Phase 3 - Proliferation (Days 4-21)
Goal: Fill the wound defect with new tissue (granulation tissue) and resurface it with epithelium.
This phase has three concurrent subprocesses:
3a. Angiogenesis (new vessel formation)
- Activated endothelial cells degrade the basement membrane of post-capillary venules
- Endothelial cells migrate into the wound along the fibrin scaffold using integrin αvβ3 (binds fibrin, fibronectin, fibrinogen)
- PECAM-1 mediates cell-cell contacts as capillary tubes form
- Stimulated by: VEGF, FGF, PDGF, TGF-β
- Results in the formation of granulation tissue - a highly vascularised, red, moist tissue filling the wound
3b. Fibroplasia (collagen synthesis by fibroblasts)
- Fibroblasts migrate into the wound along the fibrin matrix from day 4, peaking ~day 7-10
- Driven by PDGF (the key fibroblast mitogen) and TGF-β
- Fibroblasts synthesise type III collagen initially (weaker, more flexible), and later convert to type I collagen (stronger)
- Normal skin: 80% type I / 20% type III
- Early wounds: increased type III collagen
- Collagen is secreted as procollagen, cleaved extracellularly to tropocollagen, and then assembled into collagen fibrils (10-300 nm) and fibers (micrometres)
- The wound matrix also contains fibronectin, hyaluronic acid, proteoglycans - forming the ECM scaffold
- MMPs (matrix metalloproteinases) regulate matrix remodelling; MMP-1 (collagenase) is induced by IL-1 and downregulated by TGF-β; plasmin activates procollagenase to collagenase
3c. Re-epithelialisation
- Keratinocytes at the wound edge flatten, lose their attachments, and migrate across the wound surface
- Stimulated by: EGF, KGF (FGF-7), TGF-α, IL-6
- Keratinocytes proliferate behind the migrating front and eventually restore the stratified squamous epithelium
- Wound contraction (in open wounds) - myofibroblasts (fibroblasts expressing α-smooth muscle actin) contract the wound edges together, reducing wound size
Granulation tissue = capillary bed + fibroblasts + macrophages + loose collagen III + fibronectin + hyaluronic acid. Its presence signals active, healthy proliferation.
- Sabiston Textbook of Surgery | Schwartz's Principles of Surgery, 11th Ed.
Phase 4 - Maturation / Remodelling (Day 21 - 2 years)
Goal: Reorganise the collagen scaffold to maximise tensile strength; prune excess vessels and cells.
Key events:
- Type III collagen is replaced by type I collagen - fibrils become larger, cross-linked, and oriented along lines of tension
- Tensile strength increases progressively:
- Day 7: ~10% of original skin strength
- Day 21: ~30%
- Day 60: ~80%
- Maximum: ~80% of original strength is never fully recovered
- MMPs and TIMPs (tissue inhibitors of metalloproteinases) regulate this balance - MMPs degrade old collagen; TIMPs prevent excess degradation
- Excess capillaries regress - the wound becomes less red and less raised over time
- Myofibroblasts undergo apoptosis once contraction is complete
- The final scar is acellular, avascular, and less elastic than original skin
Abnormal remodelling:
-
Insufficient remodelling → dehiscence or chronic wound
-
Excessive collagen deposition → hypertrophic scar (within wound margins) or keloid (beyond wound margins)
-
Sabiston Textbook of Surgery | Schwartz's Principles of Surgery, 11th Ed.
Summary Table
| Phase | Timing | Key Cells | Key Molecules | Output |
|---|
| Haemostasis | Seconds - hours | Platelets, endothelium | vWF, thrombin, PDGF, TGF-β, fibrin | Platelet plug + fibrin clot |
| Inflammation | Days 1-4 | Neutrophils (peak d2), Macrophages (peak d3), Lymphocytes (peak d7) | IL-1, IL-6, TNF-α, ROS, NO, VEGF | Clean wound bed; cytokine gradient |
| Proliferation | Days 4-21 | Fibroblasts, endothelial cells, keratinocytes, myofibroblasts | PDGF, TGF-β, VEGF, FGF, EGF, collagen III | Granulation tissue, new vessels, epithelial cover |
| Remodelling | Day 21 - 2 years | Fibroblasts, myofibroblasts (apoptose) | MMPs, TIMPs, collagen I | Mature scar; 80% tensile strength |